Liquid-based Cytosmear

Liquid-based Cytosmear Kit

Intended use:

The detection of liquid-based cell technology is a rapid development of thin-layer cell production technology, which can replace the traditional Pap smear. In comparison, the quality of cytology production can be greatly improved, and the detection rate and accuracy of cervical cancer screening can be significantly improved.

This product can be used for smear and staining of human cell samples such as cervical exfoliated cells, cerebrospinal fluid, serosa, chest and ascites, urine, and sputum.

Registration No.: 20170694

Packing specifications: 100 tests/box; 200 tests/box

Storage conditions and expiration date: Store under dry conditions at room temperature for 24 months.

Product application range, applicable models

It can be used for liquid-based cell smear preparation of human cell samples such as cervical exfoliated cells, cerebrospinal fluid, serosa, pleural and ascites, urine, and sputum. Suitable for liquid-based thin-layer cell tableting machines.

Product advantages:

- Integrated operation: Suitable for the automatic operation of specimen processing, tableting and dyeing, and can comprehensively improve the quality of liquid-based cell production.

- Drip-dye independent wet dyeing: The drip-dye independent wet dyeing technique avoids cross-contamination and finally produces stained monolayer cell sheets with clear background, complete and clear cell morphology and monolayer distribution, which is conducive to cell morphology analysis and sample interpretation, thus improving the efficiency of diagnostic doctors and the accuracy of diagnosis results.

- Three in one technology: Gradient centrifugation, red blood cell treatment and lysis, mucus digestion technology are used to remove interfering components such as blood and mucus from liquid-based cytological specimens and enrich cells and diagnostic components.

- Wide scope of applications: It can be used for the preparation of liquid-based cell smears of cervical exfoliated cells, cerebrospinal fluid, serosa, pleural and ascites, urine, sputum and other human cell samples..

- Selective settlement: Sedimentation technology selection allows the effective capture of the diseased cells and the intact preservation of the cell structure.